Clinical Trial Update: Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation [NA]

View source ↗

Summary

Completed trial evaluating continuous glucose monitors for assessing risk of Type 2 diabetes in overweight/obese and prediabetic individuals; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity
• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• continuous glucose monitor (CGM)

Snippet

Sponsor: Mary Ellen Vajravelu, MD | Conditions: Overweight and Obesity, PreDiabetes | NA | Status: COMPLETED | Results posted: 2024-09-25